Preliminary data of a phase II randomized trial of taxotere (TXT) and doxorubicin (DOX) given simultaneously or sequentially as 1st line chemotherapy (CT) for metastatic breast cancer (MBC)

Randomized Trial ◽

Phase Ii ◽

Preliminary Data ◽

Metastatic Breast ◽

Abstract OT1-01-12: A phase II, multicenter, randomized trial of eribulin plus gemcitabine (EG) vs. paclitaxel plus gemcitabine (PG) in patients with HER2-negative metastatic breast cancer as first-line chemotherapy

10.1158/1538-7445.sabcs16-ot1-01-12 ◽

2017 ◽

Author(s):

YH Park ◽

S-A Im ◽

JH Sohn ◽

KS Lee ◽

YS Chae ◽

...

Keyword(s):

Breast Cancer ◽

Randomized Trial ◽

Phase Ii ◽

Metastatic Breast ◽

First Line ◽

Multicenter Randomized Trial ◽

Quality of life outcomes including neuropathy-associated scale from a phase II, multicenter, randomized trial of eribulin plus gemcitabine versus paclitaxel plus gemcitabine as first-line chemotherapy for HER2-negative metastatic breast cancer: Korean Can

Cancer Communications ◽

10.1186/s40880-019-0375-7 ◽

2019 ◽

Vol 39 (1) ◽

pp. 29 ◽

Cited By ~ 1

Author(s):

Ji-Yeon Kim ◽

Seri Park ◽

Seock-Ah Im ◽

Sung-Bae Kim ◽

Joohyuk Sohn ◽

...

Keyword(s):

Breast Cancer ◽

Quality Of Life ◽

Randomized Trial ◽

Phase Ii ◽

Metastatic Breast ◽

Life Outcomes ◽

First Line ◽

Safety of Herceptin monotherapy administered on a 3-weekly schedule: Preliminary data from a phase II study in women with HER2-positive metastatic breast cancer

European Journal of Cancer ◽

10.1016/s0959-8049(02)80299-4 ◽

2002 ◽

Vol 38 (11) ◽

pp. S95

Author(s):

J Baselga

Keyword(s):

Breast Cancer ◽

Phase Ii ◽

Preliminary Data ◽

Phase Ii Study ◽

Metastatic Breast ◽

Weekly Schedule ◽

Her2 Positive

230 A Phase II Study of Pegylated Liposomal Doxorubicin Combined with Cyclophosphamide / 5-fluorouracil as Second Line Chemotherapy in Patients with Metastatic Breast Cancer Who Failed Previous Taxane-based Treatment

European Journal of Cancer ◽

10.1016/s0959-8049(12)70298-8 ◽

2012 ◽

Vol 48 ◽

pp. S109-S110

Author(s):

H.K. Chang ◽

Y.C. Lin ◽

K.M. Rau ◽

Y.Y. Chen ◽

K.D. Lee ◽

...

Keyword(s):

Breast Cancer ◽

Phase Ii ◽

Liposomal Doxorubicin ◽

Phase Ii Study ◽

Metastatic Breast ◽

Pegylated Liposomal Doxorubicin ◽

Second Line ◽

Second Line Chemotherapy ◽

First-line chemotherapy of advanced or metastatic breast cancer (MBC) with docetaxel and doxorubicin in Indonesia: results from A phase II trial

Medical Journal of Indonesia ◽

10.13181/mji.v14i1.166 ◽

2005 ◽

pp. 20

Author(s):

Abdulmuthalib Abdulmuthalib ◽

Idral Darwis ◽

Nugroho Prayogo ◽

Sutjipto Sutjipto

Keyword(s):

Breast Cancer ◽

Phase Ii ◽

Phase Ii Trial ◽

Metastatic Breast ◽

First Line ◽

Randomized Phase II Trial of Weekly vs. Every 2 Weeks vs. Every 3 Weeks Nanoparticle Albumin-Bound Paclitaxel With Bevacizumab as First-Line Chemotherapy for Metastatic Breast Cancer

Clinical Breast Cancer ◽

10.1016/j.clbc.2013.02.008 ◽

2013 ◽

Vol 13 (4) ◽

pp. 239-246.e1 ◽

Cited By ~ 19

Author(s):

Andrew D. Seidman ◽

Alison K. Conlin ◽

Ariadne Bach ◽

Mary Ellen Moynahan ◽

Diana Lake ◽

...

Keyword(s):

Breast Cancer ◽

Phase Ii ◽

Phase Ii Trial ◽

Metastatic Breast ◽

First Line ◽

Randomized Phase Ii ◽

A phase II trial of docetaxel (Taxotere®) as second-line chemotherapy in patients with metastatic breast cancer

Journal of Cancer Research and Clinical Oncology ◽

10.1007/s00432-007-0259-0 ◽

2007 ◽

Vol 134 (2) ◽

pp. 125-135 ◽

Cited By ~ 9

Author(s):

Martina Baur ◽

Allan T. van Oosterom ◽

Véronique Diéras ◽

Michele Tubiana-Hulin ◽

R. Charles Coombes ◽

...

Keyword(s):

Breast Cancer ◽

Phase Ii ◽

Phase Ii Trial ◽

Metastatic Breast ◽

Second Line ◽

Second Line Chemotherapy ◽

2130 POSTER Updated analysis of an international phase II study evaluating an all-oral combination of oral vinorelbine and capecitabine as first-line chemotherapy in HER2-negative metastatic breast cancer (MBC)

European Journal of Cancer Supplements ◽

10.1016/s1359-6349(07)70892-3 ◽

2007 ◽

Vol 5 (4) ◽

pp. 223

Author(s):

N. Tubiana-Mathieu ◽

P. Bougnoux ◽

D. Becquart ◽

A. Chan ◽

F. Majois ◽

...

Keyword(s):

Breast Cancer ◽

Phase Ii ◽

Phase Ii Study ◽

Metastatic Breast ◽

First Line ◽

Oral Vinorelbine ◽

Phase II study of gemcitabine, doxorubicin and paclitaxel (GAT) as first-line chemotherapy for metastatic breast cancer: a translational research experience

BMC Cancer ◽

10.1186/1471-2407-6-76 ◽

2006 ◽

Vol 6 (1) ◽

Cited By ~ 8

Author(s):

Alessandro Passardi ◽

Ilaria Massa ◽

Wainer Zoli ◽

Lorenzo Gianni ◽

Carlo Milandri ◽

...

Keyword(s):

Breast Cancer ◽

Translational Research ◽

Phase Ii ◽

Phase Ii Study ◽

Metastatic Breast ◽

Research Experience ◽

First Line ◽

A phase II randomized trial of lapatinib with either vinorelbine or capecitabine as first- and second-line therapy for ErbB2-overexpressing metastatic breast cancer (MBC): Safety results.

Journal of Clinical Oncology ◽

10.1200/jco.2011.29.15_suppl.e11097 ◽

2011 ◽

Vol 29 (15_suppl) ◽

pp. e11097-e11097 ◽

Cited By ~ 2

Author(s):

W. Janni ◽

T. Sarosiek ◽

C. A. Papadimitriou ◽

J. V. Álvarez Gallego ◽

M. Caruso ◽

...

Keyword(s):

Breast Cancer ◽

Randomized Trial ◽

Phase Ii ◽

Metastatic Breast ◽

Second Line ◽

Second Line Therapy ◽

Line Therapy